Yumanity Therapeutics (FRA:8IY) FCF Margin % : -262.50% (As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Yumanity Therapeutics's Free Cash Flow for the three months ended in Sep. 2022 was €-3.72 Mil. Yumanity Therapeutics's Revenue for the three months ended in Sep. 2022 was €1.42 Mil. Therefore, Yumanity Therapeutics's FCF Margin % for the quarter that ended in Sep. 2022 was -262.50%.

As of today, Yumanity Therapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Yumanity Therapeutics's FCF Margin % or its related term are showing as below:

FRA:8IY' s FCF Margin % Range Over the Past 10 Years
Min: -515.15 Med: 0 Max: 0
Current: -515.15

FRA:8IY's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -143.92 vs FRA:8IY: -515.15

Yumanity Therapeutics FCF Margin % Historical Data

The historical data trend for Yumanity Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics FCF Margin % Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

FCF Margin %

-263.66

-609.80

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
FCF Margin %	Get a 7-Day Free Trial							-507.48	-1,150.30	-770.40	-319.07	-262.50

Competitive Comparison of Yumanity Therapeutics's FCF Margin %

For the Biotechnology subindustry, Yumanity Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yumanity Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yumanity Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Yumanity Therapeutics's FCF Margin % falls into.

Yumanity Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Yumanity Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-43.412	/	7.119
	=	-609.80 %

Yumanity Therapeutics's FCF Margin for the quarter that ended in Sep. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2022 )	/	Revenue (Q: Sep. 2022 )
	=	-3.717	/	1.416
	=	-262.50 %

Yumanity Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines